FOXP3 and allergic disease: At the age of 18 months, the expression of FOXP3, GATA-3, and CTLA-4 in Tregs was higher in the children with allergen-specific IgE sensitization without signs of clinical allergy when compared to the children who did not develop clinical allergies (Figure 4C).